Simplex Trading’s Galena Biopharma RXII Stock Holding History
Bought
Maintained
Sold
Simplex Trading's RXII Position: Q4 2016 in Review
Simplex Trading sold out of Galena Biopharma (RXII) in Q4 2016, closing a stake of 18,771 shares — an estimated $6K sold.
Simplex Trading first reported a position in RXII in Q3 2015 and held it in 5 quarters. The position peaked at $21K in Q2 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- Simplex Trading reported no remaining Galena Biopharma position as of Q4 2016 after selling out during the quarter.
- Simplex Trading sold 18,771 Galena Biopharma shares in Q4 2016, an estimated $6K.
- Simplex Trading first reported a position in Galena Biopharma in Q3 2015 and held it in 5 quarters.
- Simplex Trading's Galena Biopharma position peaked at $21K in Q2 2016.
- 0 funds tracked by Wall St. Rank held Galena Biopharma as of Q4 2016.
Based on Simplex Trading's 13F filing for Q4 2016, filed 11 Jan 2017.